UK markets closed

Xilio Therapeutics, Inc. (XLO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.1800-0.0800 (-6.35%)
At close: 04:00PM EDT
1.1896 +0.01 (+0.81%)
After hours: 07:25PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Operating expenses
Research development
55,397
59,201
51,188
43,910
Selling general and administrative
28,773
29,948
23,856
10,653
Total operating expenses
79,748
89,149
75,044
54,563
Operating income or loss
-84,170
-89,149
-75,044
-54,563
Total other income/expenses net
2,955
927
-756
-656
Income before tax
-81,215
-88,222
-75,800
-55,219
Income from continuing operations
-81,215
-88,222
-75,800
-55,219
Net income
-81,215
-88,222
-75,800
-55,219
Net income available to common shareholders
-81,215
-88,222
-75,800
-55,219
Basic EPS
-2.96
-3.22
-13.52
-2.07
Diluted EPS
-2.96
-3.22
-13.52
-2.07
Basic average shares
27,461
27,392
5,606
26,666
Diluted average shares
27,461
27,392
5,606
26,666